Overexpression of Fas-ligand in human nasal polyps

Annals of Otology, Rhinology and Laryngology

Volumn 109, Issue 3, 2000, Pages 267-270

  Fang, Sheen Yie ^a   Yang, Bei Chang ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Fas; Fas ligand; Nasal polyp

Indexed keywords

FAS LIGAND;

ARTICLE; CLINICAL ARTICLE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NOSE POLYP; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 0034111999     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940010900306     Document Type: Article

References (23)

1. Xaubet A, Mullol J, Lopez E, et al. Comparison of the role of nasal polyp and normal nasal mucosal epithelial cells on in vitro eosinophil survival. Mediation by GM-CSF and inhibition by dexamethasone. Clin Exp Allergy 1994;24:307-17.
2. Keith PK, Conway M, Evans S, et al. Nasal polyps: effects of seasonal allergen exposure. J Allergy Clin Immunol 1994;93:567-74.
3. Finotto S, Dolovich J, Denburg JA, Jordana M, Marshall JS. Functional heterogeneity of mast cells isolated from different microenvironments within nasal polyp tissue. Clin Exp Immunol 1994;95:343-50.
4. Linder A, Karisson-Parra A, Hirvela C. Immunocompetent cells in human nasal polyps and normal mucosa. Rhinology 1993;31:125-9.
5. Tos M, Mogensen C. Pathogenesis of nasal polyps. Int Rhinol 1977;15:87-95.
6. Nagata S, Golstein P. The Fas death factor. Science 1995; 267:1449-56.
7. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-62.
8. Suda T, Okazaki T, Naito Y, et al. Expression of the Fas ligand in cells of T cell lineage. J Immunol 1995;154:3806-13.
9. Iwai K, Miyawaki T, Takizawa T, et al. Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood 1994;84:1201-8.
10. Brunner T, Mogil RJ, Laface D, et al. Cell-autonomous Fas(cd95)/Fas-ligand interaction mediates induced apoptosis in T-cell hybridomas. Nature 1995;373:441-4.
11. Griffith TS, Yu X, Herndon JM, Green DR, Ferguson TA. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity 1996;5: 7-16.
12. French LE, Hahne M, Viard I, et al. Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J Cell Biol 1996;133:335-43.
13. Yang BC, Wang YS, Lin LC, Liu MF. Induction of apoptosis and cytokine gene expression in T cell lines by sera of patients with systemic lupus erythematosus. Scand J Immunol 1997;45:96-102.
14. Bernstein JM, Gorfien J, Noble B. Role of allergy in nasal polyposis: a review. Otolaryngol Head Neck Surg 1995;113: 724-32.
15. Ohnishi M, Ruhno J, Dolovich J, et al. Hematopoietic growth factor production by cultured cells of human nasal polyp epithelial scrapings: kinetics, cell source, and relationship to clinical status. J Allergy Clin Immunol 1989;83:1091-100.
16. Sloand EM, Young NS, Kumar P, Weichold FF, Sato T, Maciejewski JP. Role of Fas ligand and receptor in the mechanism of T-cell depletion in acquired immunodeficiency syndrome: effect on CD4+ lymphocyte depletion and human immunodeficiency virus replication. Blood 1997;89:1357-63.
17. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand - induced apoptosis as a mechanism of immune privilege. Science 1995;270:1189-92.
18. Strand S, Hofmann WJ, Hug H, et al. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand - expressing tumor cells - a mechanism of immune evasion? Nature Med 1996;2: 1361-6.
19. Hahne M, Rimoldi D, Schroter M, et al. Melanoma cell expression of Fas(Apo-1/CD95) ligand implications for tumor immune escape. Science 1996;274:1363-6.
20. Van Parijs L, Ibraghimov A, Abbas AK. The roles of co-stimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity 1996;4:321-8.
21. Sorenson CM, Padanilam BJ, Hammerman MR. Abnormal postpartum renal development and cystogenesis in the bcl-2 (-/-) mouse. Am J Physiol 1996;271:F184-F193.
22. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
23. Cui H, Sherr DH, el-Khatib M, et al. Regulation of T-cell death genes: selective inhibition of Fas-L but not Fas-mediated function. Cell Immunol 1996;167:276-84.